Trial intelligence / Profile preview

Antibiotics effect on IIV immune response

NCT02154061Completed

Sponsor
Emory University
Start
Apr 2015
Primary completion
May 2017
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Randomised, open-label trial of Fluzone Trivalent in influenza (2 arms), sponsored by Emory University. Primary endpoint: Participants With Four Fold Rise in HAI Titers or HAI 1:40 and Above at 30 days. Started Apr 2015; status: completed.

02

Drugs

Fluzone Trivalent
03

Conditions

influenza

Beyond the preview

Go deeper on NCT02154061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02154061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call